ClinConnect ClinConnect Logo
Search / Trial NCT05525221

Societal Merit of Intervention on Hearing Loss Evaluation

Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Aug 30, 2022

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Cochlear Implantation

ClinConnect Summary

This clinical trial is studying the long-term effects of cochlear implants (CIs) on people with progressive hearing loss, specifically those who have trouble hearing due to damage to the inner ear. The researchers want to see how getting a cochlear implant can improve various aspects of life, such as communication, independence, work performance, and overall quality of life. They will also look at how the waiting time for surgery affects these outcomes.

To participate, you need to be an adult who is eligible for a cochlear implant according to specific guidelines and willing to join the study. The trial is open to individuals aged 65 and older, as well as those younger than 65. However, certain individuals, like children, people with complex medical issues, or those who can't work for reasons unrelated to hearing, will not be included. If you join, you can expect to undergo assessments about your hearing and daily activities before and after receiving a cochlear implant, helping researchers understand how this intervention can make a difference in your life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (potentially) eligible for CI according to the Dutch quality standard for CI (Veldnorm CI 2013) and willing to participate. Participants are divided in 2 age categories (under and over 65 years old)
  • Exclusion Criteria:
  • People with a complex syndrome with multiple problems.
  • Incapable of performing paid or unpaid labor, due to non-hearing related factors
  • Prelingual onset of deafness.
  • Children 0 - 18 years old.
  • Non-native Dutch speakers.
  • Patients suffering from a psychiatric disorder
  • Any condition that may hamper a complete insertion of the electrode array or a normal rehabilitation with the cochlear implant (severe otosclerosis or neurologic deficits)

About Radboud University Medical Center

Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.

Locations

Utrecht, , Netherlands

Nijmegen, Gelderland, Netherlands

Maastricht, Limburg, Netherlands

Amsterdam, Noord Holland, Netherlands

Leiden, Zuid Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Emmanuel Mylanus

Study Director

Radboud University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials